BIO: Scancell director tells of plans for success and signs licensing deal with NIH
This article was originally published in Scrip
Executive Summary
The UK cancer vaccine company Scancell's commercial director Dr Richard Goodfellow is confident that its melanoma vaccine will secure a buyer for the company by 2012, he told Scrip at this year's BIO International Convention, held in Chicago from 3-6 May.